Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 55, Issue 5, 1996, Pages 328-330

  McInnes, I B ^a   Porter, D ^a   Murphy, E A ^a   Thomson, E A ^a   Madhok, R ^a   Hunter, J A ^b   Pullar, T ^c   Capell, H A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DOUBLE BLIND PROCEDURE; DRUG TOXICITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN TOXICITY;

EID: 0029890052     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.5.328     Document Type: Article

References (12)

1. Pullar T, Hunter J A, Capell H A. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol 1985; 24: 269-76.
2. Capell H A, Porter D, Madhok R, Hunter J A. Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis 1993; 52: 423-8.
3. Grindulis K A, McConkey B. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone. Ann Rheum Dis 1984; 43: 398-401.
4. Situnayake R D, Grindulis K A, McConkey B. Long term treatment of rheumatoid arthritis with sulphasalazine, gold or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987; 46: 177-83.
5. Amos R S, Pullar T, Bax D E, Situnayake D, Capell H A, McConkey B. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to eleven years. BMJ 1985; 293: 420-5.
6. Marabani M, Madhok R, Capell H A, Hunter J A. Leucopenia during sulphasalazine treatment for rheumatoid arthritis. Ann Rheum Dis 1989; 48: 505-7.
7. Bax D E, Amos R S. Sulphasalazine in rheumatoid arthritis; desensitising the patient with a skin rash. Ann Rheum Dis 1986; 45: 139-40.
8. Pullar T, Hunter J, Capell H A. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987; 46: 398-402.
9. Felson D, Anderson J J, Meenan R F. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Arthritis Rheum 1990; 33: 1449-59.
10. Porter D R, McInnes I B, Hunter J, Capell H A. Outcome of second line therapy in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 812-5.
11. Van der Heijde D M F M, Van Riel P, Nuver-Zwart I, van de Putte L. Effects of hydroxychloroquine and sulphasalazine on the progression of joint damage in rheumatoid arthritis. Lancet 1989; 335: 1036-8.
12. Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.